What really separates The Wire from the work Simon and company did after it is how entertaining the series is, featuring colorful characters like Michael K. To an extent, David Simon and his collaborators have lived in its shadow since then. While it took a while to gain a following, The Wire was eventually recognized as one of the greatest TV series of all time. It also drew on an underutilized pool of Black actors to create iconic characters, including breakout roles for major stars like Idris Elba and Michael B. Drawing parallels between the police, drug gangs, declining industry, local politics, and schools, The Wire was like nothing else that came before it. Beginning as the story of Baltimore police trying to take down a drug ring, The Wirebecame a sprawling picture of a failing American city and its dysfunctional institutions. While Simon's shows often take a while to be recognized and receive little awards attention, they have attracted critical praise, especially dark police drama The Wire, which has often been suggested in discussions regarding what the best TV show ever is.ĭespite many years having passed since its inception, American crime drama The Wire is still commonly regarded as the best David Simon TV show, and not undeservingly. This led David Simon to begin creating his own shows, beginning with The Corner, also based on a journalistic book written by Simon and Ed Burns. The book was adapted into a critically acclaimed NBC series Homicide: Life on the Street, with Simon becoming a writer and executive producer on the show. Simon worked as a crime reporter for The Baltimore Sun for 13 years, including writing the book Homicide: A Year on the Killing Streets. None of Simon's series are bad, but some of them are more dramatically successful than others. The former reporter has produced three full series and five miniseries, all for HBO, and all taking a realistic and journalistic approach to issues facing America. During law school, he won several writing awards for work in constitutional law and intellectual property law.David Simon has created some of the most distinctive and critically acclaimed television shows of the 21st century. He earned his B.A., with high honors, from the University of Michigan, and his J.D., with high honors, from Chicago-Kent College of Law, where he was selected to the Moot Court Honor Society, Order of the Coif, and Dean’s List. from the University of Cambridge, where he was a Cambridge International Scholar (full tuition scholarship & stipend) and member of Trinity College. from Harvard Law School, where he was a Summer Academic Fellow, and a Ph.D. Ashman at the United States District Court for the Northern District of Illinois.ĭavid holds an LL.M. He also served as a judicial law clerk to the Honorable Martin C. He also served as a volunteer attorney for Lawyers for the Creative Arts. His clients included hedge fund managers, investment firms, small businesses, physicians, professional athletes, homeless veterans, singers, songwriters, and artists. Before entering academia, David represented clients in corporate, business, real estate, and intellectual property transactions. Previously, David taught at The George Washington University Law School, the University of Kansas School of Law, and the Hanken School of Economics in Helsinki, Finland. He is also working on projects related to drug and device regulation and innovation the philosophy of intellectual property and “law.” His research has been published, or is forthcoming, in a variety of legal and medical publications, including the Boston College Law Review, the Emory Law Journal, the Florida Law Review, the Georgia Law Review, the Journal of Law & the Biosciences, the Journal of Law, Medicine, & Ethics, Nature Medicine, the Washington Law Review, the William & Mary Law Review, and the Yale Journal of Law & Technology. David’s current research at Petrie-Flom focuses on identifying and addressing the legal, ethical, and practical challenges involved in home-based diagnostic and monitoring technology. Food and Drug Administration (FDA), and the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). He is also a Member of the CURE Drug Repurposing Collaboratory, which is a public-private partnership under the auspices of the Critical Path Institute (C-Path), in partnership with the U.S. Simon is a Lecturer on Law at Harvard Law School and a Research Fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology, & Bioethics, also at Harvard Law School.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |